{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:25:30Z","timestamp":1793154330875,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T00:00:00Z","timestamp":1742860800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00415-025-13030-2","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T00:41:56Z","timestamp":1743122516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Global trends and projections of Parkinson\u2019s disease incidence: a 30-year analysis using GBD 2021 data"],"prefix":"10.1007","volume":"272","author":[{"given":"Libo","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingsong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,25]]},"reference":[{"key":"13030_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40035-023-00378-6","volume":"12","author":"ZD Zhou","year":"2023","unstructured":"Zhou ZD, Yi LX, Wang DQ, Lim TM, Tan EK (2023) Role of dopamine in the pathophysiology of Parkinson\u2019s disease. Transl Neurodegener 12:44","journal-title":"Transl Neurodegener"},{"key":"13030_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13024-019-0332-6","volume":"14","author":"A Masato","year":"2019","unstructured":"Masato A, Plotegher N, Boassa D, Bubacco L (2019) Impaired dopamine metabolism in Parkinson\u2019s disease pathogenesis. Mol Neurodegener 14:35","journal-title":"Mol Neurodegener"},{"key":"13030_CR3","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30:1591\u20131601","journal-title":"Mov Disord"},{"key":"13030_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3390\/ijms18030551","volume":"18","author":"R Cacabelos","year":"2017","unstructured":"Cacabelos R (2017) Parkinson\u2019s disease: from pathogenesis to pharmacogenomics. Int J Mol Sci 18:551","journal-title":"Int J Mol Sci"},{"key":"13030_CR5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s40035-019-0165-9","volume":"8","author":"SY Pang","year":"2019","unstructured":"Pang SY, Ho PW, Liu HF et al (2019) The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson\u2019s disease. Transl Neurodegener 8:23","journal-title":"Transl Neurodegener"},{"key":"13030_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.776847","volume":"9","author":"Z Ou","year":"2021","unstructured":"Ou Z, Pan J, Tang S et al (2021) Global trends in the incidence, prevalence, and years lived with disability of Parkinson\u2019s disease in 204 countries\/territories from 1990 to 2019. Front Public Health 9:776847","journal-title":"Front Public Health"},{"key":"13030_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Bloem BR (2018) The Parkinson pandemic\u2014a call to action. JAMA Neurol 75:9\u201310","journal-title":"JAMA Neurol"},{"key":"13030_CR8","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"GBDN Collaborators","year":"2019","unstructured":"Collaborators GBDN (2019) Global, regional, and national burden of neurological disorders, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18:459\u2013480","journal-title":"Lancet Neurol"},{"key":"13030_CR9","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"GBD Diseases","year":"2024","unstructured":"Diseases GBD, Injuries C (2024) Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 403:2133\u20132161","journal-title":"Lancet"},{"key":"13030_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s13534-022-00226-y","volume":"12","author":"A Malvea","year":"2022","unstructured":"Malvea A, Babaei F, Boulay C, Sachs A, Park J (2022) Deep brain stimulation for Parkinson\u2019s disease: a review and future outlook. Biomed Eng Lett 12:303\u2013316","journal-title":"Biomed Eng Lett"},{"key":"13030_CR11","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","volume":"18","author":"AHV Schapira","year":"2017","unstructured":"Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18:435\u2013450","journal-title":"Nat Rev Neurosci"},{"key":"13030_CR12","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S0140-6736(20)30977-6","volume":"396","author":"GBDD Collaborators","year":"2020","unstructured":"Collaborators GBDD (2020) Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950\u20132019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet 396:1160\u20131203","journal-title":"Lancet"},{"key":"13030_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","volume":"390","author":"Collaborators GBDCoD","year":"2017","unstructured":"Collaborators GBDCoD (2017) Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 390:1151\u20131210","journal-title":"Lancet"},{"key":"13030_CR14","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","volume":"388","author":"GA Stevens","year":"2016","unstructured":"Stevens GA, Alkema L, Black RE et al (2016) Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet 388:e19\u2013e23","journal-title":"Lancet"},{"key":"13030_CR15","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1002\/sim.2764","volume":"26","author":"B Carstensen","year":"2007","unstructured":"Carstensen B (2007) Age-period-cohort models for the Lexis diagram. Stat Med 26:3018\u20133045","journal-title":"Stat Med"},{"key":"13030_CR16","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s13524-019-00801-6","volume":"56","author":"E Fosse","year":"2019","unstructured":"Fosse E, Winship C (2019) Bounding analyses of age-period-cohort effects. Demography 56:1975\u20132004","journal-title":"Demography"},{"key":"13030_CR17","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1158\/1055-9965.EPI-14-0300","volume":"23","author":"PS Rosenberg","year":"2014","unstructured":"Rosenberg PS, Check DP, Anderson WF (2014) A web tool for age-period-cohort analysis of cancer incidence and mortality rates. Cancer Epidemiol Biomarkers Prev 23:2296\u20132302","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"13030_CR18","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","volume":"17","author":"Collaborators GBDPsD","year":"2018","unstructured":"Collaborators GBDPsD (2018) Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 17:939\u2013953","journal-title":"Lancet Neurol"},{"issue":"6","key":"13030_CR19","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","volume":"119","author":"CM Tanner","year":"2011","unstructured":"Tanner CM, Kamel F, Ross GW et al (2011) Rotenone, paraquat, and Parkinson\u2019s disease. Environ Health Perspect 119(6):866\u2013872","journal-title":"Environ Health Perspect"},{"issue":"5","key":"13030_CR20","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.etp.2012.02.006","volume":"65","author":"L Calder\u00f3n-Garcidue\u00f1as","year":"2013","unstructured":"Calder\u00f3n-Garcidue\u00f1as L, Serrano-Sierra A, Torres-Jard\u00f3n R et al (2013) The impact of environmental metals in young urbanites\u2019 brains. Exp Toxicol Pathol 65(5):503\u2013511","journal-title":"Exp Toxicol Pathol"},{"issue":"5","key":"13030_CR21","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1093\/ajcn\/86.5.1486","volume":"86","author":"X Gao","year":"2007","unstructured":"Gao X, Chen H, Fung TT et al (2007) Prospective study of dietary pattern and risk of Parkinson disease. Am J Clin Nutr 86(5):1486\u20131494","journal-title":"Am J Clin Nutr"},{"key":"13030_CR22","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.3390\/nu14132592","volume":"14","author":"X Zhang","year":"2022","unstructured":"Zhang X, Zhang L, Pu Y et al (2022) Global, regional, and national burden of protein-energy malnutrition: a systematic analysis for the global burden of disease study. Nutrients 14:2592","journal-title":"Nutrients"},{"issue":"4","key":"13030_CR23","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/jnnp.2003.020982","volume":"75","author":"GF Wooten","year":"2004","unstructured":"Wooten GF, Currie LJ, Bovbjerg VE, Lee JK, Patrie J (2004) Are men at greater risk for Parkinson\u2019s disease than women? J Neurol Neurosurg Psychiatry 75(4):637\u2013639. https:\/\/doi.org\/10.1136\/jnnp.2003.020982","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13030_CR24","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1210\/er.2016-1007","volume":"37","author":"A Villa","year":"2016","unstructured":"Villa A, Vegeto E, Poletti A, Maggi A (2016) Estrogens, neuroinflammation, and neurodegeneration. Endocr Rev 37:372\u2013402","journal-title":"Endocr Rev"},{"key":"13030_CR25","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-pharmtox-011613-135937","volume":"54","author":"SM Goldman","year":"2014","unstructured":"Goldman SM (2014) Environmental toxins and Parkinson\u2019s disease. Annu Rev Pharmacol Toxicol 54:141\u2013164","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"13030_CR26","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/jamaneurol.2022.1783","volume":"79","author":"N Schiess","year":"2022","unstructured":"Schiess N, Cataldi R, Okun MS et al (2022) Six action steps to address global disparities in Parkinson disease: a world health organization priority. JAMA Neurol 79:929\u2013936","journal-title":"JAMA Neurol"},{"key":"13030_CR27","doi-asserted-by":"publisher","first-page":"1386608","DOI":"10.3389\/fneur.2024.1386608","volume":"15","author":"R Bhidayasiri","year":"2024","unstructured":"Bhidayasiri R, Sringean J, Phumphid S et al (2024) The rise of Parkinson\u2019s disease is a global challenge, but efforts to tackle this must begin at a national level: a protocol for national digital screening and \u201ceat, move, sleep\u201d lifestyle interventions to prevent or slow the rise of non-communicable diseases in Thailand. Front Neurol 15:1386608","journal-title":"Front Neurol"},{"key":"13030_CR28","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.3390\/antiox11122467","volume":"11","author":"S Pyatha","year":"2022","unstructured":"Pyatha S, Kim H, Lee D, Kim K (2022) Association between heavy metal exposure and Parkinson\u2019s disease: a review of the mechanisms related to oxidative stress. Antioxidants (Basel) 11:2467","journal-title":"Antioxidants (Basel)"},{"key":"13030_CR29","doi-asserted-by":"publisher","first-page":"41175","DOI":"10.1007\/s11356-020-10539-z","volume":"27","author":"A Iqubal","year":"2020","unstructured":"Iqubal A, Ahmed M, Ahmad S, Sahoo CR, Iqubal MK, Haque SE (2020) Environmental neurotoxic pollutants: review. Environ Sci Pollut Res Int 27:41175\u201341198","journal-title":"Environ Sci Pollut Res Int"},{"key":"13030_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0291357","volume":"18","author":"S Crooks","year":"2023","unstructured":"Crooks S, Carter G, Wilson CB et al (2023) Exploring public perceptions and awareness of Parkinson\u2019s disease: a scoping review. PLoS ONE 18:e0291357","journal-title":"PLoS ONE"},{"key":"13030_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12916-023-02933-4","volume":"21","author":"AD Geerlings","year":"2023","unstructured":"Geerlings AD, Kapelle WM, Sederel CJ et al (2023) Caregiver burden in Parkinson\u2019s disease: a mixed-methods study. BMC Med 21:247","journal-title":"BMC Med"},{"key":"13030_CR32","first-page":"S168","volume":"18","author":"DF Boland","year":"2012","unstructured":"Boland DF, Stacy M (2012) The economic and quality of life burden associated with Parkinson\u2019s disease: a focus on symptoms. Am J Manag Care 18:S168-175","journal-title":"Am J Manag Care"},{"key":"13030_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.952161","volume":"10","author":"C Ding","year":"2022","unstructured":"Ding C, Wu Y, Chen X et al (2022) Global, regional, and national burden and attributable risk factors of neurological disorders: The Global Burden of Disease study 1990\u20132019. Front Public Health 10:952161","journal-title":"Front Public Health"},{"issue":"4","key":"13030_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S1474-4422(06)70411-2","volume":"5","author":"A Schrag","year":"2006","unstructured":"Schrag A, Schott JM (2006) Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. Lancet Neurol 5(4):355\u2013363","journal-title":"Lancet Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13030-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13030-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13030-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T06:09:35Z","timestamp":1744956575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13030-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,25]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["13030"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13030-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,25]]},"assertion":[{"value":"8 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The studies involving human participants were reviewed and approved based on data released from the Global Health Data Exchange, which did not necessitate informed patient consent. This research utilized an anonymized publicly accessible dataset that contained no identifiable information regarding the survey participants. In accordance with national legislation and institutional requirements, written informed consent for participation was not required for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"286"}}